Develops integrated manufacturing solutions and automated systems to scale production and reduce costs for cell therapy manufacturing.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Cellares offers integrated development and manufacturing solutions for cell therapy. It leverages its advanced technology platform, including the Cell Shuttle™ system, to scale production, reduce costs, and improve quality in cell therapy manufacturing. Their services cater to preclinical, clinical, and commercial phases, aiming to accelerate access to life-saving treatments.
Cellares Funding
Sign up to gain insights into Cellares funding history, including the funding round, time period, and amount raised.
| Financing Round | Date | Amount | Price per share | Valuation |
|---|---|---|---|---|
| Round | Date | Amount | PPS | Valuation |
| Series D | Jun 09, 2026 | 20M | ||
| Series D | Jan 28, 2026 | 257M | ||
| Series C | Aug 15, 2023 | 225M | ||
| Series C | Aug 15, 2023 | 31M | ||
| Series B | Apr 12, 2021 | 80M | ||
| Series B | Apr 12, 2021 | 2M | ||
| Series A | Aug 07, 2019 | 18M |
Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Cellares Management Team
Cellares Valuations & Financials
View real-time NPM data on Cellares stock including daily Cellares stock price estimates, valuation history, and historical share price information. Access Cellares financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Cellares pricing across six independent market signals. Looking for private company due diligence data sources on Cellares? Get in touch to learn more.
Similar Companies
like Cellares
Color
Healthcare & Life Sciences
Physician-ordered genetic testing with comprehensive support, utilizing advanced software and a certified laboratory.
Cityblock
Healthcare & Life Sciences
Tech-driven care provider for communities with complex needs.
Hinge Health
Healthcare & Life Sciences
Digital clinic for back, joint, and muscle pain.
Benchling
Healthcare & Life Sciences
Cloud based platform for research and development in biotechnology.
Lyra
Healthcare & Life Sciences
Digital health startup using technology to connect companies and employees to mental health providers.
Eikon Therapeutics
Healthcare & Life Sciences
Uses revolutionary technology to discover novel treatments for life-threatening diseases.
Resilience
Healthcare & Life Sciences
Operates as technology-focused biomanufacturing company dedicated to broadening access to complex medicines.
Devoted Health
Healthcare & Life Sciences
Provides Medicare Advantage plans to improve older Americans' well-being with comprehensive and family-oriented care.
FAQ
We have answers
Cellares stock does not trade on public stock exchanges. Cellares stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Cellares stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Cellares Stock does not trade on public stock exchanges. In order to sell Cellares shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Cellares does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Cellares share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Cellares stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Cellares stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Cellares stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Cellares is a private company and has not had an IPO. There is currently no Cellares IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Cellares IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
